Stock Market Reactions to FDA Complete Response Letter Disclosures: Evidence from Deficiency Types, Firm Characteristics, and Tail Risk

SSRN Electronic Journal 2026 Preprint Open access

Read full text

Authors: Pranav Muralitharan, Anoushka Banerjee

DOI: 10.2139/ssrn.6027774

Cited by: 0

References: 8

Fields of Study & Subjects

Pharmaceutical Economics and Policy Pharmacovigilance and Adverse Drug Reactions Pharmaceutical industry and healthcare

References 8